The Evolving Roles of Human iPSC-Derived Cardiomyocytes in Drug Safety and Discovery

被引：65
|
作者：
Gintant, Gary [1 ]
Fermini, Bernard [2 ]
Stockbridge, Norman [3 ]
Strauss, David [4 ]
机构：
[1] AbbVie, Integrated Sci & Technol, Dept Integrat Pharmacol ZR13, Bldg AP-9A LL,1 North Waukegan Rd, N Chicago, IL 60064 USA
[2] Coyne Sci, 58 Edgewood Ave NE, Atlanta, GA 30303 USA
[3] US FDA, Ctr Drug Evaluat & Res, Div Cardiovasc & Renal Prod, Silver Spring, MD 20993 USA
[4] US FDA, Ctr Drug Evaluat & Res, Div Appl Regulatory Sci, Silver Spring, MD 20993 USA
来源：
CELL STEM CELL | 2017年 / 21卷 / 01期
关键词：
CARDIOTOXICITY;
D O I：
10.1016/j.stem.2017.06.005
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
Nonclinical studies of drug effects with human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) provide new possibilities for evaluating drug safety and efficacy. The Comprehensive In Vitro Proarrhythmia Assay (CiPA) paradigm provides lessons from the cardiac field that also apply to drug studies with other stem cell-based assays.
引用
收藏
页码：14 / 17
页数：4
相关论文
共 50 条
  • [21] Integrated electrophysiologic analyses of amiodarone in human iPSC-derived cardiomyocytes
    Bhagavan, Druv
    Moreno, Jonathan D.
    Kernik, Divya C.
    Guo, Jingxuan
    Huebsch, Nathaniel
    Silva, Jonathan R.
    BIOPHYSICAL JOURNAL, 2022, 121 (03) : 235A - 235A
  • [22] Characterization of Sarcolemmal KAtp Channels in Human Ipsc-derived Cardiomyocytes
    Geiger, Robert
    Fatima, Naheed
    Klein, Michael
    Goldstein, Robert E.
    Haigney, Mark C.
    Flagg, Thomas P.
    CIRCULATION, 2020, 142
  • [23] Expanding the number of validated iPSC-derived cardiomyocytes for safety pharmacology studies
    Armstrong, Annie
    Himmerich, Sarah
    Livingston, Megan K.
    Carlson, Coby B.
    Rieger, Cara R.
    Vaidyanathan, Ravi
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2021, 111
  • [24] High throughput physiological screening of iPSC-derived cardiomyocytes for drug development
    del Alamo, Juan C.
    Lemons, Derek
    Serrano, Ricardo
    Savchenko, Alex
    Cerignoli, Fabio
    Bodmer, Rolf
    Mercola, Mark
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2016, 1863 (07): : 1717 - 1727
  • [25] A Predictive Electrophysiological Assay on Human iPSC-Derived Cardiomyocytes for Comprehensive Cardiac Safety/Toxicity Assessment
    Goineau, Sonia
    Avril, Quentin
    Legrand, Christophe
    Froget, Guillaume
    Castagne, Vincent
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2017, 88 : 237 - 237
  • [26] Frequency-dependent drug screening using optogenetic stimulation of human iPSC-derived cardiomyocytes
    Lapp, Hendrik
    Bruegmann, Tobias
    Malan, Daniela
    Friedrichs, Stephanie
    Kilgus, Carsten
    Heidsieck, Alexandra
    Sasse, Philipp
    SCIENTIFIC REPORTS, 2017, 7
  • [27] Electrophysiological Characteristics of Human iPSC-Derived Cardiomyocytes for the Assessment of Drug-Induced Proarrhythmic Potential
    Yamamoto, Wataru
    Asakura, Keiichi
    Ando, Hiroyuki
    Taniguchi, Tomohiko
    Ojima, Atsuko
    Uda, Takaaki
    Osada, Tomoharu
    Hayashi, Seiji
    Kasai, Chieko
    Miyamoto, Norimasa
    Tashibu, Hiroyuki
    Yoshinaga, Takashi
    Yamazaki, Daiju
    Sugiyama, Atsushi
    Kanda, Yasunari
    Sawada, Kohei
    Sekino, Yuko
    PLOS ONE, 2016, 11 (12):
  • [28] Frequency-dependent drug screening using optogenetic stimulation of human iPSC-derived cardiomyocytes
    Hendrik Lapp
    Tobias Bruegmann
    Daniela Malan
    Stephanie Friedrichs
    Carsten Kilgus
    Alexandra Heidsieck
    Philipp Sasse
    Scientific Reports, 7
  • [29] iPSC-Derived Hepatocytes as a Platform for Disease Modeling and Drug Discovery
    Corbett, James L.
    Duncan, Stephen A.
    FRONTIERS IN MEDICINE, 2019, 6
  • [30] Multi-lineage Human iPSC-Derived Platforms for Disease Modeling and Drug Discovery
    Sharma, Arun
    Sances, Samuel
    Workman, Michael J.
    Svendsen, Clive N.
    CELL STEM CELL, 2020, 26 (03) : 309 - 329
12345